Tengion - Product Pipeline Analysis
Tengion, Inc. (Tengion) is a biopharmaceutical company, which discovers, manufactures and commercializes a variety of neo-organs and neo-tissues, derived from the patients' own cells. The company has its own integrated technology named Organ Regeneration Platform, which harnesses an individual's body ability to regenerate organs and tissues. Currently, the company is conducting clinical trials on Neo-Urinary Conduit for bladder cancer patients and Neo-Kidney Augment for patients suffering from advanced chronic kidney disease. The company is conducting Phase I clinical trial for...
View full press release